Now showing items 1-1 of 1
Synthesis and preclinical evaluation of peptide receptor-targeted diagnostic and therapeutic radiopharmaceuticals for prostate cancer
(University of Missouri--Columbia, 2019)
human prostate cancer cells. The last portion of the work described in this dissertation focuses on 105Rh as a potential therapeutic radionuclide. Rhodium-105 (t1/2 = 35.4 hours) is a moderate energy beta-emitting radionuclide [ [beta] avg = 152 ke...